Review ArticleInternational Journal of Basic & Clinical Pharmacology

Publication:
Pathophysiological and pharmacological modulation of melatonergic system

Int J Basic Clin Pharmacol. 2015;4(4):632-639.DOI10.18203/2319-2003.ijbcp20150363

Thumbnail Image
View on the journal's website(opens in a new tab)

Abstract

Pineal gland once considered as rudimentary or vestigial, has become a principal endocrine gland that regulates the body’s internal environment, after the discovery of melatonin - a hormone produced by it. Melatonin is also synthesized from extra-pineal sites such as retina, skin, platelets, bone marrow, and gastrointestinal tract. The chronobiological property of this hormone in maintaining the circadian rhythm by synchronizing with the dark-light cycle is well-established. Melatonin also possesses anti-inflammatory, anti-depressant, anti-oxidant, oncostatic, immunomodulatory, antiepileptic, and glucose-regulating properties. These pleiotropic effects of melatonin on diverse organ systems either through a receptor or non-receptor mediated pathways are under investigation. This review highlights the pathophysiological and pharmacological actions of melatonin along with melatonergic agonists in “real life” clinical practice.

Keywords

Affiliations

  1. Department of Pharmacology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India

Full item record